Malhotra S, Costa C, Eixarch H, Keller CW, Amman L, Martinez-Banaclocha H, Midaglia L, Sarro E, Machin-Diaz I, Villar LM, Trivino JC, Oliver-Martos B, Parlade LN, Calvo-Barreiro L, Matesanz F, Vandenbroeck K, Urcelay E, Martinez-Gines ML, Tejeda-Velarde A, Fissolo N, Castillo J, Sanchez A, Robertson AAB, Clemente D, Prinz M, Pelegrin P, Lunemann JD, Espejo C, Montalban X, Comabella M. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients. Brain. 2020 May 1;143(5):1414-1430. doi: 10.1093/brain/awaa084. PubMed PMID: 32282893.
AÑO: 2020; IF: 13.501